DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to speed healing for fragile skin disease
Disease control Recruiting nowThis study is testing whether adding IV IgG (intravenous immunoglobulin) to an existing gene therapy (VYJUVEK) helps wounds heal faster and better in people with recessive dystrophic epidermolysis bullosa (RDEB). It will enroll 8 participants who already have significant blisteri…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated Apr 04, 2026 03:50 UTC
-
New eye drop trial aims to soothe painful scratches in 'Butterfly Skin' disease
Disease control Recruiting nowThis study is testing whether an investigational eye drop called KB803 can safely reduce the frequency and pain of corneal abrasions (scratches on the eye's surface) in people with dystrophic epidermolysis bullosa (DEB), a rare genetic skin disorder. Participants will use either …
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Experimental gel aims to heal fragile skin in 'Butterfly Children'
Disease control Recruiting nowThis study is testing a gel called TCP-25 to see if it helps heal skin wounds in people with epidermolysis bullosa (EB), a condition that causes extremely fragile, blistering skin. In the trial, each participant will have two similar wounds treated—one with the TCP-25 gel and one…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE2 • Sponsor: Xinnate AB • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New topical therapy trial offers hope for 'Butterfly Skin' wound healing
Disease control Recruiting nowThis early-stage clinical trial is testing whether a topical gel called EV.FV can help heal wounds in people with dystrophic epidermolysis bullosa, a severe genetic skin condition. The treatment uses tiny particles from stem cells to deliver healing signals directly to the skin. …
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: Isfahan University of Medical Sciences • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC